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ABSTRACT 
Seasonal variation in the occurrence of several classes of cancer has been observed in the 
past. However, evidence for such trends in adult central nervous system tumors is scant. 
We have analyzed the monthly occurrence rates of glioblastomas as well as carcinomas 
metastatic to the brain in 6,154 neurosurgical patients in Toronto selected from the 
University Health Network neuropathologic database over a seven-year period (July 2001 
to June 2008). The electronic repository was representative of the patient population in 
southern Ontario, and the case accession dates in the database reflected the onset patterns of 
the selected tumor groups. A modification to Nam’s alternative method to the Roger test 
was developed to statistically quantify the differences. The results demonstrated significant 
cyclical occurrence rates of glioblastomas with seasonal peaks in March, June, September 
and December. Moreover, significant increases in the rates of carcinomas metastatic to the 
brain were found for January, April and August. Surprisingly, the monthly frequency for 
the two tumor groups resembled each other in peak/trough topology. Semiquantitative 
comparison of major histologic features between glioblastomas from a peak (March) and 
trough (November) month in the seven-year period was performed, revealing differences in 
the amount of perivascular lymphocytic inflammation. This novel observation may have 
profound implications for the understanding of the biology of adult central nervous system 
tumors. 
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INTRODUCTION 
Understanding seasonal variations in disease occurrence can provide insights into 
pathogenesis which may have diagnostic and therapeutic implications. The identification of 
seasonal trends for a number of cancers has led to the investigation of potential causative 
environmental factors. Examples include prostate [1], thyroid [2] and skin cancers [3], 
which have been linked to the effect of varying daylight and UV radiation on vitamin D 
synthesis. Exposure to infectious agents has been implicated in the seasonality of cervical 
cancer [4], lymphomas [5] and frog adenocarcinomas [6, 7]. Similar correlations have been 
proposed for breast cancer with pineal biorhythms and expression of progesterone receptor 
[8]. However, no definitive consensus for seasonal patterns in breast cancer exists [9, 10]. 
Associations between season of birth and occurrence of brain tumors have been 
reported [11, 12], pointing to possible pre- or postnatal effects. To our knowledge, the only 
reported observation of seasonal variation in adult malignant brain tumors was made from 
the Tumorzentrum Regensburg database in southeastern Germany [13]. The investigators 
reported circannual periodicity for glioblastomas in women but not in men.  
The current study presents further evidence for periodicity in the occurrence of 
glioblastomas and carcinomas metastatic to the central nervous system (CNS) over a seven-
year period in Toronto, Canada. In addition, histological analysis of glioblastomas suggests 
the presence of seasonally-variable inflammatory and vascular events.  
 
PATIENTS AND METHODS 
Cases were selected from a neuropathologic database created from print and electronic 
archives at Toronto’s University Health Network spanning 1971 to the present and 
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containing more than 31,000 specimens [14]. A seven-year period was chosen for the 
current study (July 2001 to June 2008). Two groups of tumors were selected for review: 
glioblastomas and metastatic carcinomas. Recurrent or previously treated cases were 
excluded. Anatomic locations were restricted to the cerebrum and cerebellum. Tumors were 
grouped by month of surgery, and frequency was calculated relative to the total number of 
neurosurgical cases in that month. Gender-based trends were also assessed. All queries of 
the database conformed to the University Health Network Research Ethics Board 
guidelines. In particular, no information was extracted from the repository that could lead 
to the recognition of patient identities. 
To investigate the biological basis of seasonal trends in glioblastomas, 
histopathology was compared between a peak (March) and a trough (November) month of 
frequency. Hematoxylin and eosin-stained sections of these tumors were reviewed by two 
neuropathologists (S.E.C. and T.R.K.) blinded to the month of surgery. Six major 
microscopic features (necrosis, pseudopalisades, microvascular proliferation, thrombosis, 
perivascular lymphocytic inflammation and hemosiderin deposition) were scored 
semiquantitatively as absent (0), minimal (1) or extensive (2). 
Statistical analyses for seasonality studies are classically performed using the Roger 
test [15]. An alternative method increases power by utilizing the premises of the hypothesis 
being examined [16]. It assumes two seasons to be proportionally constant, the third to 
have peaked, and the fourth to be below average. For the seasonality analyses in this study, 
we used a modification of Nam’s method (see Supplement). The major peaks in each trend 
were tested for significance against other monthly values, which were assumed to have 
minor variation relative to the yearly average. Statistical significance tests for histological 
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analyses were performed using a two-sample, one-tailed Student’s t-test assuming equal 
variance, with P-values less than 0.05 considered significant.  
 
RESULTS 
Among the 6,154 neurosurgical cases in the selected period, 505 glioblastomas (316 males, 
189 females, mean age = 58.6 ± 14.3) and 386 metastatic carcinomas (167 males, 219 
females, mean age = 59.6 ± 11.8) were found. Gender distribution among all cases was 
48.3% female and 51.7% male, with no particular gender being overrepresented in a given 
month. The frequency trend for glioblastomas showed highly significant peaks in March, 
June, September and December (Z = 3.329, P = 0.0004), and metastatic carcinomas 
demonstrated peaks in January, April and August (Z = 2.697, P = 0.0035) (Figure 1A). 
Therefore, the peak/trough patterns of the two tumor groups closely resembled each other. 
Furthermore, no significant gender differences were observed (Figures 1B, C). 
Histologic evaluation of all glioblastoma cases from a peak (n = 33) and trough (n = 
32) month demonstrated a significant increase in the amount of perivascular lymphocytic 
inflammation (P = 0.048) in the trough month (Figure 2). There were no significant 
differences in other histologic features, namely thrombosis (P = 0.167), hemosiderin (P = 
0.175), pseudopalisades (P = 0.208), necrosis (P = 0.233) and vascular proliferation (P = 
0.336). 
 
DISCUSSION 
We have demonstrated significant seasonal variation in the presentation of both 
glioblastoma and CNS-metastatic carcinoma. The degree of malignancy and rapid growth 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
09
.2
96
9.
1 
: P
os
te
d 
24
 M
ar
 2
00
9
 6 
of these lesions usually mandates surgery within a short time after first clinical symptoms, 
ensuring a close correlation between initial presentation and the true occurrence of the 
disease. Moreover, the use of the frequency of diagnosis as a fraction of total neurosurgical 
cases rather than the number of diagnoses in this study eliminated potential effects of 
external variables, such as the number of neurosurgeons on duty or level of experience of 
the surgical staff in any given month. In addition, the months chosen for histological 
analysis did not constitute typical vacation times or periods of unusual surgical load. 
The trend found for glioblastoma cases in our series is similar to that reported by 
Koch and colleagues (2005), who demonstrated significant peaks in March and September 
in female patients. Unlike that study, however, no gender differences were found in our 
series. The number of glioblastomas analyzed in the mentioned report (501 cases between 
1992 and 2003) was comparable to the study presented here. The male : female ratios 
(approximately 1.5 : 1) for glioblastomas were also consistent with reported values [17].  
Alternative statistical methods for seasonality analyses based on the date of clinical 
diagnosis and utilizing the von Mises distribution and angular regression methods have 
been suggested [18]. However, due to the existence of technical difficulties with these 
approaches as detailed by Gao et al. (2006), and the configuration of our database, we 
decided to group our data on a monthly basis and develop an extension to a model 
suggested earlier (see Supplement). 
Histological comparison of glioblastomas revealed an increase in perivascular 
inflammation in a trough month (Figure 2). This observation could (i) suggest a protective 
role of inflammation, or (ii) point to an anticipation for an increased number of 
glioblastoma cases following the trough month. Seasonality in CNS vascular events is a 
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well-established phenomenon, as demonstrated by variation in the onset of primary 
intracerebral haemorrhage [19], spontaneous carotid artery dissections and intracranial 
aneurysms [20]. Seasonal variation in cytokine response has also been documented. Levels 
of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) after endotoxin stimulation 
result in a pro-inflammatory reaction in early summer and an anti-inflammatory reaction in 
early autumn [21]. This variation could theoretically manifest itself as the change in 
perivascular inflammatory infiltrate observed in this study. This cytokine pair may also 
play a role in the progression of gliomas [22, 23]. Moreover, it is possible that the 
development of malignant carcinomas to a metastatic stage is related to underlying 
circannually-varying factors, as infiltrative edges in breast cancer have been observed more 
frequently in the first half of the year [24]. 
Definite conclusions about associations between the observed trends in malignant 
brain tumors with environmental variability in the Northern Hemisphere are still premature. 
The effect of temperature on metastasis of renal carcinoma in frogs, which has viral origins, 
has been described [25]. Furthermore, release of interleukins and other cytokines by 
rhinoviruses or in influenza infections has been established [26, 27]. A possible link 
between seasonal temperatures, common infection rates in the general population and 
cancer metastasis warrants further investigation. Additionally, circannual changes in 
vitamin D levels, small-molecule hormones (e.g. melatonin), glucose intake and 
atmospheric aerosol levels together with seasonal changes in the protective actions of 
activated glial cells and inflammation could be future areas of research. As a direct follow-
up to our study, histological analysis could be expanded to include additional years and 
immunohistochemical studies for cytokines and their receptors, hormone receptors and 
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other markers. The findings could also be correlated with neuroimaging, treatment and 
outcome. 
In summary, we present evidence for seasonal variation in the presentation of 
malignant primary and metastatic brain tumors. We suggest that further studies linking this 
to seasonal variations in pro-inflammatory cytokines may help to understand biological 
events underlying the progression of these neoplasms. As the population in southern 
Ontario, and consequently their representation in our database, is very heterogeneous (2006 
Census), we expect that our findings are not limited to one genetic group and could prove 
true in other geographic regions. This could lead to diagnostic and therapeutic conclusions 
with widespread applicability. 
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FIGURE LEGENDS 
 
 
Fig. 1: Seasonal patterns of presentation. (A) Analysis of frequency of glioblastoma 
cases per total monthly cases revealed highly significant peaks in March, June, September 
and December. For metastatic carcinomas, there were peaks in January, April and August. 
Frequencies of glioblastoma diagnoses therefore closely resemble the trend for metastatic 
carcinomas. Gender-specific analysis demonstrates close resemblance of the combined 
graphs, notwithstanding male bias in glioblastoma cases (B) and female bias in the 
combined metastatic carcinoma cases (C). 
 
Fig. 2: Histological comparison. Glioblastoma cases from a peak and trough month were 
compared in six major neuropathological features. The trough month showed a significant 
increase in the amount of perivascular lymphocytic inflammation. 
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Supplement – Ehsani et al., Seasonality of adult brain tumour presentation 
Modified Score Statistic  
 
We assume we have the following data:  
t1, t2, t3, … , t12 → counts of specified tumour in months 1 through 12 
n1, n2, n3, … , n12 → total tumour counts in months 1 through 12 
 
Also define p1, p2, p3 , … , p12 be the proportions of the specified tumour in months 1 
through 12. Note that we do not necessarily have p1 + p2 + p3 + … + p12 = 1; however, if 
there is no seasonality then p1 = p2 = p3 = … = p12. 
     We suspect that p1 and p2 (say) may be higher than the other pi’s. This can be modeled 
as follows:  
 
p1 = p2 = p + b          p3 = … = p12 = p  
where p and b are unknown parameters. For this model, we want to test the null hypothesis 
H0 : b = 0 
against some appropriate alternative hypothesis H1  
(either (i) b ≠ 0, (ii) b > 0, or (iii) b < 0).  
     Using a modification of the multinomial model in Nam (1995), it is possible to derive a 
score test for H0. The sign test statistic for testing H0 can be computed as 
Z = 
D
N  
where 
N   =   (t1 + t2 )(n3 + … + n12 ) − (t3 + … + t12 )(n1 + n2 ) 
D   =   {(t1 + … + t12 )(n1 + n2 )(n3 + … + n12 )}1/2. 
      
     The rejection region for an α level test of H0 depends on the alternative hypothesis: 
 H1 : b ≠ 0 reject H0 for |Z| > z (1−α/2) 
 H1 : b > 0 reject H0 for Z > z (1−α) 
 H1 : b < 0 reject H0 for Z < −z (1−α) 
where z (1−α) and z (1−α/2) are as defined in Nam (1995). 
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